May 17, 2024
Get the scoop on the hottest topics in compounding
EduCon’s first session is in less than two months, and you don’t want to miss it.
May 17, 2024
South Carolina allows 503B sourcing
Kudos to the Outsourcing Facilities Association for their work in shepherding through South Carolina HB 3592. Signed into law on Monday, it explicitly allows 503B sourcing.
May 10, 2024
A terrific tool to train the team
Our 15-hour virtual course is a thorough, convenient, and affordable resource for learning the ethical, legal, and regulatory framework in which compounding is done.
May 10, 2024
We’re headed for Tampa! (Oh, and Boston, too)
We’ll be in the Tampa/St. Pete area on June 12 for our next CompoundED UpDATE — part of a series of regional meetings made possible by a grant from PCCA. We’ll also be in Boston on June 18 for a compounder get-together.
May 10, 2024
Celltechgen is APC’s newest supporter
Celltechgen, a testing lab for microbe endotoxin and sterility, potency, and more, has joined APC as a Bronze-level Corporate Patron.
May 10, 2024
Meet our compounding defenders (and guardians and champions)
A few weeks ago, we offered you a deal. Since then, several of you have taken us up on it — so here’s a big thank you to our Package Deal investors.
May 10, 2024
Exploring career path options for technicians
APC’s Jen Petska is the featured guest on the latest CPhT Connect podcast, “the only weekly podcast specifically for pharmacy technicians.” Give a listen.
May 3, 2024
Journalistic malpractice
This piece is appalling – both the bias and error in the article itself AND that Pharmacy Times would take a swipe at a legitimate pharmacy practice like pharmacy compounding.
May 3, 2024
Let’s get together
APC may soon be coming to a city near you — and we’d love to meet up. We’ll be in the Tampa/St. Pete area on June 12 for our next CompoundED UpDATE — part of a series of regional meetings made possible by a grant from PCCA.
May 3, 2024
NABP gets it right in their latest report
Drugmakers, newsmedia, and even regulators have been wrongly conflating legitimate compounding of GLP-1s with illegal online drug sales. In their latest RogueRx Activity Report, NABP doesn’t make that mistake.
